| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19
|
Seethamraju, Harish
|
|
|
46 |
11 |
p. 891-899
|
artikel
|
| 2 |
A Retrospective Cross-Sectional Analysis of the Humanistic and Economic Burden of Bipolar I Disorder
|
Culpepper, Larry
|
|
|
46 |
11 |
p. 855-864
|
artikel
|
| 3 |
Association Between Prior Antiplatelet Therapy and Prognosis in Patients With Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis
|
Zhang, Hanxu
|
|
|
46 |
11 |
p. 905-915
|
artikel
|
| 4 |
Bariatric Surgery Underutilization in Young Postadolescent Population With Obesity
|
Ginsberg, Ariana S.
|
|
|
46 |
11 |
p. e29-e33
|
artikel
|
| 5 |
Budget Impact Analysis of Dapagliflozin in Treating Patients With Heart Failure With Reduced Ejection Fraction From the Perspective of Malaysian Public Healthcare System
|
Tan, Yi Jing
|
|
|
46 |
11 |
p. e1-e9
|
artikel
|
| 6 |
Clinical Update on an Anti-Alzheimer Drug Candidate CT1812: A Sigma-2 Receptor Antagonist
|
Kaur, Guramrit
|
|
|
46 |
11 |
p. e21-e28
|
artikel
|
| 7 |
Cost-Effectiveness of Zanubrutinib Versus Bendamustine and Rituximab in Patients With Untreated Chronic Lymphocytic Leukemia
|
Nie, Jing
|
|
|
46 |
11 |
p. 877-882
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
46 |
11 |
p. i-ii
|
artikel
|
| 9 |
Effect of Everolimus on Prognosis of Neurofibromatosis Type 1 Lesions: A Systematic Review and Meta Analysis
|
Ibrahim, Ismail A.
|
|
|
46 |
11 |
p. 865-869
|
artikel
|
| 10 |
Extraglycemic Effects of SGLT2i/GLP1-ra: A Topic Update
|
Alam, Uazman
|
|
|
46 |
11 |
p. 826-827
|
artikel
|
| 11 |
Newer Glucose-Lowering Drugs and Risk of Gout: A Network Meta-Analysis of Randomized Outcomes Trials
|
Wang, Aihua
|
|
|
46 |
11 |
p. 851-854
|
artikel
|
| 12 |
No Differences in Kidney Function Decline Between People With Type 2 Diabetes Starting a Sodium-Glucose Cotransporter 2 Inhibitor or a Glucagon-like Peptide-1 Receptor Agonist: A Real-world Retrospective Comparative Observational Study
|
Bodini, Sara
|
|
|
46 |
11 |
p. 828-834
|
artikel
|
| 13 |
Oncology Dose Selection in Subsequent Indications: What Can We Learn From FDA-approved Oncology Drugs?
|
Ngo, Huy X.
|
|
|
46 |
11 |
p. 927-937
|
artikel
|
| 14 |
Optimizing Acute Ischemic Stroke Outcomes: The Role of Tenecteplase Before Mechanical Thrombectomy
|
Haj Mohamad Ebrahim Ketabforoush, Arsh
|
|
|
46 |
11 |
p. e10-e20
|
artikel
|
| 15 |
Pharmacokinetics and Pharmacodynamics of a Fixed-Dose Combination of Esomeprazole and Magnesium Hydroxide Compared to the Enteric-Coated Esomeprazole
|
Kim, Yoonjin
|
|
|
46 |
11 |
p. 870-876
|
artikel
|
| 16 |
Risk Factors for E2SKAPE Infections and Mortality Among Liver Transplant Recipients
|
Wu, Xiaoxia
|
|
|
46 |
11 |
p. 883-890
|
artikel
|
| 17 |
SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of Gout in People Living With Type 2 Diabetes Across the Therapeutic Spectrum
|
Preston, Frank G.
|
|
|
46 |
11 |
p. 835-840
|
artikel
|
| 18 |
Silver Linings: Side Effects and Secondary Findings of Newly Emerging Therapies
|
Maron, Jill L.
|
|
|
46 |
11 |
p. 825
|
artikel
|
| 19 |
Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Coronary Syndrome: A Modern Cinderella?
|
Karakasis, Paschalis
|
|
|
46 |
11 |
p. 841-850
|
artikel
|
| 20 |
The Totality of Evidence for SDZ-deno: A Biosimilar to Reference Denosumab
|
Vogg, Barbara
|
|
|
46 |
11 |
p. 916-926
|
artikel
|
| 21 |
Topical Application of 0.05% Cyclosporine for the Treatment of Neurotrophic Keratopathy Secondary to Herpes Simplex Keratitis
|
Liao, Ruochen
|
|
|
46 |
11 |
p. 900-904
|
artikel
|
| 22 |
Xanomeline and Trospium Chloride
|
Beninger, Paul
|
|
|
46 |
11 |
p. 938-939
|
artikel
|
Tijdschrift beschrijving